Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about AKBA
Recent news which mentions AKBA
< Previous
1
2
3
4
5
Next >
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 10, 2022
Tickers
AHCO
AKAN
AKBA
BBLG
Tags
Intraday Update
SDC
BHVN
From
Benzinga
Stocks That Hit 52-Week Lows On Friday
April 08, 2022
Tickers
ACIW
AFIB
AGFY
AGS
Tags
CTLP
Options
Markets
From
Benzinga
See Why Does HC Wainwright Maintain Neutral On Akebia Stock
April 07, 2022
Tickers
AKBA
Tags
Benzinga
AKBA
Analyst Color
From
Benzinga
FDA Places Partial Hold On Vadadustat Pediatric Studies, Akebia Cuts Over 40% Staff
April 07, 2022
Tickers
AKBA
Tags
News
General
Health Care
From
Benzinga
Stocks That Hit 52-Week Lows On Monday
April 04, 2022
Tickers
ABCB
AFIB
AKBA
ALVR
Tags
WMC
SFNC
EVOK
From
Benzinga
The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight
April 03, 2022
Tickers
ACAD
AKBA
AMLX
AMRX
Tags
FDA
BTAI
Biotech
From
Benzinga
Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates
April 01, 2022
Tickers
ABBV
AKBA
ALNY
AMRX
Tags
REGN
General
News
From
Benzinga
Stocks That Hit 52-Week Lows On Friday
April 01, 2022
Tickers
ABCB
ABOS
ACOR
AEO
Tags
GALT
JHX
NYCB
From
Benzinga
53 Biggest Movers From Yesterday
April 01, 2022
Tickers
AFIB
AKBA
AREC
AUUD
Tags
AKBA
RCMT
HILS
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2022
March 31, 2022
Tickers
ACET
AFMD
AKBA
AMD
Tags
MORF
HLIO
CCO
From
Benzinga
51 Biggest Movers From Yesterday
March 31, 2022
Tickers
ADGI
AKBA
AMBC
ARHS
Tags
HILS
CALA
Small Cap
From
Benzinga
6 Stocks Halted In Wednesday's Session
March 30, 2022
Tickers
AKBA
BNOX
DO
GLOB
Tags
News
BNOX
DO
From
Benzinga
FDA Rejects Akebia Therapeutics' Vadadustat For CKD-Associated Anemia
March 30, 2022
Tickers
AKBA
OTSKY
Tags
OTSKY
Briefs
Trading Ideas
From
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 30, 2022
Tickers
ADGI
AKBA
BNOX
CALA
Tags
Market News
Top Gainers
HILS
From
Benzinga
35 Stocks Moving In Wednesday's Mid-Day Session
March 30, 2022
Tickers
ADGI
AKBA
AMBC
ARHS
Tags
INDO
Trading Ideas
PSO
From
Benzinga
The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia
March 29, 2022
Tickers
AKBA
ALDX
AMPE
ATRS
Tags
Market News
CRMD
PAVM
From
Benzinga
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
March 27, 2022
Tickers
ADMP
AFIB
AFMD
AGRX
Tags
SPRO
Earnings
AKBA
From
Benzinga
7 Biotech Stocks With Key Catalysts in March
March 09, 2022
Tickers
AKBA
AMLX
ARNA
ASND
Tags
IBB
PFE
ASND
From
InvestorPlace
Akebia Therapeutics Earnings Perspective: Return On Capital Employed
March 03, 2022
Tickers
AKBA
Tags
Earnings
BZI/ROCE
Benzinga
From
Benzinga
Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates
March 02, 2022
Tickers
AGIO
AKBA
AMLX
ATRS
Tags
ATRS
BMY
Top Stories
From
Benzinga
Recap: Akebia Therapeutics Q4 Earnings
March 01, 2022
Tickers
AKBA
Tags
Benzinga
AKBA
Market News
From
Benzinga
Earnings Scheduled For March 1, 2022
March 01, 2022
Tickers
ADT
ADV
AGEN
AIV
Tags
EHTH
JAZZ
RDNT
From
Benzinga
7 Speculative Penny Stocks Worth a Roll of the Dice
February 25, 2022
Tickers
AKBA
AUY
CLNV
EVTV
Tags
AKBA
AUY
NYSE:AUY,NASDAQ:USEG,NASDAQ:MRIN,NASDAQ:AKBA,NASDAQ:REDU,OTCMKTS:EVTV,OTCMKTS:CLNV
From
InvestorPlace
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development
February 23, 2022
Tickers
AKBA
ARNA
AVNS
BHC
Tags
IBB
ARNA
GH
From
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 04, 2022
Tickers
AHPI
AKBA
ELDN
GTBP
Tags
NRBO
Market News
Movers
From
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 30, 2021
Tickers
ABEO
AKBA
ARDS
AVEO
Tags
KPRX
BIIB
VALN
From
Benzinga
Akebia Therapeutics, inc (AKBA) Q3 2021 Earnings Call Transcript
November 09, 2021
Tickers
AKBA
Tags
Recent Press Releases
Market News
AKBA
From
Motley Fool
7 Small-Cap Stocks to Buy From the Beat-Up Bargain Bin
October 11, 2021
Tickers
AKBA
ALTO
BW
CLIR
Tags
BW
NASDAQ:AKBA,NASDAQ:ALTO,NYSE:BW,NASDAQ:CLIR,NYSEAMERICAN:GOED,NASDAQ:HIMX,NASDAQ:SNDL,NYSE:XOM
Stocks to Buy
From
InvestorPlace
Why FibroGen Fell by More Than 9% on Wednesday
September 22, 2021
Tickers
AKBA
FGEN
GS
Tags
Market News
GS
AKBA
From
Motley Fool
After FDA Rejection, EMA Approves FibroGen-Astellas' Roxadustat
August 20, 2021
Tickers
AKBA
ALPMF
ALPMY
AZN
Tags
News
General
Penny Stocks
From
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.